期刊文献+

高迁移率蛋白B1对血管平滑肌细胞迁移的影响及分子机制研究 被引量:2

Effect of HMGB1 on the migration of vascular smooth muscle cells and its molecular mechanism
下载PDF
导出
摘要 目的探讨高迁移率蛋白B1(HMGB1)对血管平滑肌细胞(VSMCs)迁移的影响及TLR4依赖的TLR4/PI3K/Akt信号通路介导的分子机制。方法体外分离培养大鼠胸主动脉VSMCs,采用不同浓度HMGB1(0.1-1 000.0ng/mL)处理,分为对照组(未经任何处理)、HMGB1组、HMGB1+TLR4siRNA转染组、Control siRNA转染组和磷脂酰肌醇3-激酶(PI3K)抑制剂(LY294002)干预组,观察各组细胞活性及HMGB1对VSMCs迁移的影响;实时定量RT-PCR与Western blot分别检测TLR4、Akt、p-Akt、PI3K mRNA和蛋白的表达;ELISA测定PI3K的活性。结果 HMGB1(0.1-1 000.0ng/mL)呈剂量依赖性促进VSMCs迁移(P〈0.05);经细胞活性测定,HMGB1在使用的浓度范围内对VSMCs未造成细胞毒性作用(P〈0.05);HMGB1(100ng/mL)处理的VSMCs细胞组PI3K活性及Akt磷酸化水平明显增加(P〈0.05);经TLR4siRNA转染发现,HMGB1引起的VSMCs迁移明显减弱(P〈0.05),同样在PI3k抑制剂干预组,PI3K/Akt途径活化和HMGB1介导的VSMCs迁移也被明显抑制(P〈0.05)。结论 HMGB1呈剂量依赖性促进VSMCs迁移,TLR4依赖的TLR4/PI3K/Akt信号通路参与了此过程,提示以TLR4依赖的PI3K/Akt途径为靶点,可为阻塞性血管疾病的治疗提供新思路。 Objective To investigate the effect of high mobility group box-1(HMGB1)on the migration of vascular smooth cells(VSMCs)and the role of TLR4-dependent PI3K/Akt pathway in the process.Methods Primary VSMCs were isolated from the thoracic aorta of male SD rats and cultured in vitro.Control group,TLR4 siRNA transfected group,control siRNA transfected group and PI3kinhibitor(LY294002)intervention group were stimulated by HMGB1(0.1-1 000.0ng/mL).Expression of TLR4 mRNA was detected by RT-PCR,protein expression of TLR4,Akt,pAkt,PI3 K were detected by Western blot.Activity of the immunoprecipitated PI3 Kenzyme was assessed in a competitive ELISA.The migration and cell viability of every groups were observed.Results HMGB1(0.1-1 000.0ng/mL)stimulated VSMCs migration in a dose-dependent manner and incubation of VSMCs with 100ng/mL caused a rapid migration(P〈0.05).At the concentrations used,HMGB1 did not cause any cytotoxic effects(P〈0.05).Migration of VSMCs toward HMGB1 was significantly inhibited by silencing of TLR4(P〈0.05).Pretreated cells with TLR4 siRNA or the PI3 Kinhibitor LY294002could markedly block PI3K/Akt pathway activation and VSMCs migration mediated by HMGB1(both P〈0.05).Conclusion HMGB1 stimulated VSMCs migration in a dose-dependent manner and TLR4-dependent PI3K/Akt signaling pathway played an important role in the migration of VSMCs mediated by HMGB1.This research indicates that TLR4-dependent TLR4/PI3K/Akt signaling pathway could be the target in the treatment of obstructive cardiovascular disease.
出处 《重庆医学》 CAS 北大核心 2015年第4期439-441,445,共4页 Chongqing medicine
基金 国家自然科学基金资助项目(81200088) 宜昌市科技研究与开发项目(A12301-01)
关键词 TOLL样受体4 高迁移率蛋白B1 PI3K/AKT信号通路 血管平滑肌细胞 Toll-like receptor 4 high mobility group box-1 PI3K/Akt pathway vascular smooth muscle cells
  • 相关文献

参考文献13

  • 1Jukema JW, Ahmed TA. Verschuren J J, el al. Reslenosis after PCI. Part 2: prevention and therapy[J]. Nat Rev Cardiol, 2011,9 ( 2 ) : 79-90.
  • 2Montezano AC, Callera GE, Yogi A, et al. Aldosterone and angiotensin Ⅱ synergistically stimulate migration in vascular smooth muscle cells through c- Src-regulated redox-sensitive RhoA pathways[J]. Arte- rioscler Thromb Vasc Biol,2008,28(8):1511-1518.
  • 3Ding HS,Yang J,Chen P,et al. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis[J]. Gene, 2013,527 (1) :389-393.
  • 4Smolarczyk R,Cichon T,Jarosz M,et al. HMGB1--its role in tumor progression and anticancer therapy[J]. Postepy Hig Med Dosw,2012,66(3) :913-920.
  • 5Kierdorf K,Fritz G. RAGE regulation and signaling in inflam- mation and beyond[J].J Leukoc Biol,2013,94(1):55-68.
  • 6Bianchi ME,Mardredi AA. High-mobility group box I(HMGB1) protein at the crossroads between innate and adaptive immunity [J]. Immunol Rev, 2007,220:35- 46.
  • 7Yang J, Huang C, Yang J, et al. Statins attenuate high mobility group box-1 protein induced vascular endothelial activation..a key role for TLR4/NF-κB signaling pathway [J]. Mol Cell Biochem,2010,345(1/2):189-195.
  • 8Heo SK,Yun HJ,Noh EK,et al. LPS induces inflamma- tory responses in human aortic vascular smooth muscle cells via Toll-like receptor 4 expression and nitric oxide production[J]. Immunol Lett, 2008,120 ( 1/2 ) : 57-64.
  • 9Gouffic Y,Guilluy C, Guerin P, et al. Hyaluronan induces vascular smooth muscle cell migration through RHAMM- mediated PI3K-dependent Rac activation[J]. Cardiovasc Res,2006,72(2) :339-348.
  • 10Ojaniemi M, Glumoff V, Harj u K, et al. Phosphatidylinos- itol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages[J]. Gut J Im- munol,2003,33(3) :597-605.

同被引文献25

  • 1Takasawa Y, Iijima R, Shiba M, et al. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention[J]. J Cardiol, 2010, 55(3): 391-396.
  • 2Jukema JW, Ahmed TA, Verschuren J J, et al. Restenosis after PCI. Part 2: prevention and therapy[J]. Nat Rev Cardiol, 2012, 9(2): 79- 90.
  • 3Harris HE, Andersson U, Pisetsky DS. HMGBI: a multifunctional alarmin driving autoimmune and inflammatory disease[J]. Nat RevRheumatol, 2012, 8(4): 195-202.
  • 4Yang J, Chen L, Yang J, et al. High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent P13K/Akt pathway activation[J]. Mol Biol Rep, 2012, 39(3):3361- 3367.
  • 5Qin YH, Dai SM, Tang GS, et al. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products[J]. J Immunol, 2009, 183(10):6244-6250.
  • 6Kokkola R, Andersson A, Mullins G, et al. RAGE is the major receptor for the proinflammatory activity of HMGBI in rodent macrophages[J]. Scand J Immunol, 2005, 61(1): 1-9.
  • 7Wildgruber M, Weiss W, Berger H, et al. Association of Circulating Transforming Growth Factor beta, Tumor Necrosis Factor alpha and Basic Fibroblast Growth Factor with Restenosis after Transluminal Angioplasty[J]. Eur J Vasc Endovas Surg, 2007, 34(1 ): 35-43.
  • 8Yang J, Zeng Y, Li Y, et al. Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis[J]. Eur J Pharm Sci, 2008, 35(5):427-434.
  • 9Nakagawa M, Ohno T, Maruyama R, et al. Sesquiterpene lactone suppresses vascular smooth muscle cell proliferation and migration via inhibition of cell cycle progression[J]. Biol Pharm Bull, 2007, 30(9): 1754-1757.
  • 10Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box l[J]. Proc Natl Acad Sci USA, 2004, 101(1):296-301.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部